Substance use disorder privacy law limits both payers, prescribers

April 27, 2017
Op-Ed on substance abuse disorder privacy statute
Kimberly Lenz, PharmD, MBA, FAMCP
Commonwealth Medicine

We should reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder, UMass Medical School pharmacists Kimberly Lenz and Tyson Thompson write in an opinion piece for Managed Healthcare Executive.

Substance use disorder privacy law limits both payers, prescribers